Form 4: USANA Health Sciences Director Acquires Shares Through Vesting of Restricted Stock Units
SEC Form 4 Filing
Director J. Scott Nixon acquired 674 shares of USANA Health Sciences common stock through the vesting of restricted stock units.
Summary
- J. Scott Nixon, a director at USANA Health Sciences, acquired 674 shares of common stock on February 2, 2025.
- This acquisition resulted from the vesting of restricted stock units.
- The restricted stock units vest in four tranches: 25% on August 2, 2024, November 2, 2024, February 2, 2025, and May 2, 2025.
- Each restricted stock unit represents the right to receive one share of USNA common stock.
- Following the transaction, Mr. Nixon directly owns 4,909 shares of USANA common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns interests. There is no indication of any negative or unexpected events.
Positives
- The vesting of restricted stock units aligns the director's interests with those of the shareholders.
- The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
Industry Context
This is a routine filing related to the vesting of equity compensation for a company director, which is a common practice in publicly traded companies.
Comparison to Industry Standards
- The vesting schedule of 25% per quarter is a fairly standard vesting schedule for restricted stock units.
- Many companies use similar equity compensation plans to align the interests of directors and employees with those of shareholders.
- The use of restricted stock units is a common practice among publicly traded companies, including those in the health and wellness sector.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 08/02/2024 | 25% of the restricted stock units vested. |
| 11/02/2024 | 25% of the restricted stock units vested. |
| 02/02/2025 | 25% of the restricted stock units vested and the director acquired 674 shares of common stock. |
| 05/02/2025 | 25% of the restricted stock units will vest. |
| 02/03/2025 | Date of the filing of the Form 4. |
Keywords
USANA Health Sciences, Director, Stock Acquisition, Restricted Stock Units, Vesting, Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.